• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

-158γ(C→T)Xmn1 多态性对印度镰状细胞病患者的调节作用。

Modulating Effect of the -158 γ (C→T) Xmn1 Polymorphism in Indian Sickle Cell Patients.

机构信息

Department of Hematology, AIIMS, New Delhi, India.

出版信息

Mediterr J Hematol Infect Dis. 2012;4(1):e2012001. doi: 10.4084/MJHID.2012.001. Epub 2012 Jan 15.

DOI:10.4084/MJHID.2012.001
PMID:22348183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3279316/
Abstract

Xmn1 polymorphism is a known factor, which increases fetal haemoglobin production. Among the inherited disorders of blood, thalassaemia and Sickle Cell Diseases contributes to a major bulk of genetic diseases in India. Our aim was to verify the role of the Xmn1 polymorphism as a modulating factor in sickle cell patients and frequency of the polymorphism in Indian sickle cell patients. 60 sickle homozygous and 75 sickle beta thalassemia patients were included and 5 ml blood sample was collected from them. Screening of sickle patients was done by HPLC. An automated cell analyzer SYSMEX (K-4500 Model) was used to analyze the Complete Blood Count of patients. Xmn1 polymorphism analysis was done by PCR-RFLP and one-way ANOVA test was applied to analysis of variance between groups. Among the sickle patients 27 were heterozygous (+/-) and 19 were homozygous (+/+) while 30 were heterozygous (+/-) and 24 were homozygous (+/+) in sickle β-thalassemia patients. Extremely significant differences (p-value <0.001) of hematological parameters seen among patients with Xmn1 carrier and without the Xmn1 carrier. In our cases the clinical symptoms were barely visible and higher HbF level with Xmn1 carriers were found. Presence of Xmn1 polymorphism in sickle cell patients with higher HbF were phenotypically distinguished in the sickle cell patients. We conclude that the phenotypes of Indian sickle cell patients were greatly influenced by Xmn1polymorphism.

摘要

Xmn1 多态性是一个已知的因素,它可以增加胎儿血红蛋白的产生。在血液遗传疾病中,地中海贫血和镰状细胞病在印度的遗传疾病中占很大比例。我们的目的是验证 Xmn1 多态性作为镰状细胞病患者的调节因子的作用,以及该多态性在印度镰状细胞病患者中的频率。纳入了 60 名镰状纯合子和 75 名镰状β地中海贫血患者,并从他们身上采集了 5 毫升血样。通过 HPLC 对镰状细胞患者进行筛查。使用自动细胞分析仪 SYSMEX(K-4500 型)分析患者的全血细胞计数。通过 PCR-RFLP 进行 Xmn1 多态性分析,应用单因素方差分析检验组间方差。在镰状细胞患者中,27 名是杂合子(+/-),19 名是纯合子(+/+),而在镰状β-地中海贫血患者中,30 名是杂合子(+/-),24 名是纯合子(+/+)。在 Xmn1 携带者和非 Xmn1 携带者的患者中,观察到血细胞参数有极显著差异(p 值<0.001)。在我们的病例中,临床症状几乎看不见,Xmn1 携带者的 HbF 水平较高。在镰状细胞病患者中存在 Xmn1 多态性,与 HbF 较高的患者在表型上有区别。我们得出结论,Xmn1 多态性极大地影响了印度镰状细胞病患者的表型。

相似文献

1
Modulating Effect of the -158 γ (C→T) Xmn1 Polymorphism in Indian Sickle Cell Patients.-158γ(C→T)Xmn1 多态性对印度镰状细胞病患者的调节作用。
Mediterr J Hematol Infect Dis. 2012;4(1):e2012001. doi: 10.4084/MJHID.2012.001. Epub 2012 Jan 15.
2
A study on the genotype frequency of -158 Gγ (C→T) 1 polymorphism in a sickle cell trait cohort from Siwa Oasis, Egypt.埃及锡瓦绿洲镰状细胞性状队列中 -158 Gγ (C→T) 1 多态性的基因型频率研究。
J Genet. 2018 Jun;97(2):505-511.
3
Xmn1-G γ polymorphism and clinical predictors of severity of disease in β-thalassemia intermedia.Xmn1-Gγ 多态性与β-地中海贫血中间型疾病严重程度的临床预测因子。
Pediatr Blood Cancer. 2011 Dec 1;57(6):1025-8. doi: 10.1002/pbc.23175. Epub 2011 Jul 13.
4
Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.加纳镰状细胞病患儿珠蛋白及相关基因中特定单核苷酸多态性与羟基脲治疗反应的关联
Pharmgenomics Pers Med. 2022 Mar 10;15:205-214. doi: 10.2147/PGPM.S351599. eCollection 2022.
5
The Xmn1 polymorphic site 5' to the (G)gamma gene and its correlation to the (G)gamma:(A)gamma ratio, age at first blood transfusion and clinical features in beta-thalassemia patients from Western Iran.伊朗西部β地中海贫血患者中,(G)γ基因5'端的Xmn1多态性位点及其与(G)γ:(A)γ比值、首次输血年龄和临床特征的相关性。
Mol Biol Rep. 2010 Jan;37(1):159-64. doi: 10.1007/s11033-009-9566-7. Epub 2009 May 15.
6
A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population.伊朗人群中β地中海贫血基因型与表型相关性的大型队列研究。
Int J Hematol Oncol Stem Cell Res. 2015 Oct 1;9(4):198-202.
7
Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh.恰蒂斯加尔邦镰状细胞病患者中XmnI多态性与HbF水平的关联
Int J Biomed Sci. 2012 Mar;8(1):36-9.
8
Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.BCL11A、HSB1L-MYB 和 XmnI γG-158(C/T)基因多态性与埃及镰状细胞病患者血红蛋白 F 水平的关联。
Ann Hematol. 2020 Oct;99(10):2279-2288. doi: 10.1007/s00277-020-04187-z. Epub 2020 Aug 9.
9
Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients.印度镰状细胞病患者中HMOX1基因多态性(rs2071746:A > T)的患病率及影响
J Lab Physicians. 2023 Jun 19;15(4):583-589. doi: 10.1055/s-0043-1770068. eCollection 2023 Dec.
10
Sickle Cell Disease in Central India: A Potentially Severe Syndrome.印度中部的镰状细胞病:一种潜在的严重综合征。
Indian J Pediatr. 2016 Oct;83(10):1071-6. doi: 10.1007/s12098-016-2081-7. Epub 2016 Apr 7.

引用本文的文献

1
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.遗传变异与镰状细胞病严重程度:系统评价和荟萃分析。
JAMA Netw Open. 2023 Oct 2;6(10):e2337484. doi: 10.1001/jamanetworkopen.2023.37484.
2
The rs7482144 (C > T) Polymorphism is Linked to HbF Levels but not to the Severity of Sickle Cell Anemia.rs7482144(C>T)多态性与胎儿血红蛋白水平相关,但与镰状细胞贫血的严重程度无关。
J Pediatr Genet. 2021 Aug 31;12(2):129-134. doi: 10.1055/s-0041-1733950. eCollection 2023 Jun.
3
Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.加纳镰状细胞病患儿珠蛋白及相关基因中特定单核苷酸多态性与羟基脲治疗反应的关联
Pharmgenomics Pers Med. 2022 Mar 10;15:205-214. doi: 10.2147/PGPM.S351599. eCollection 2022.
4
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.遗传修饰因子影响胎儿血红蛋白对羟基脲治疗镰状细胞病患者病程的影响。
Haematologica. 2022 Jul 1;107(7):1577-1588. doi: 10.3324/haematol.2021.278952.
5
A study on the genotype frequency of -158 Gγ (C→T) 1 polymorphism in a sickle cell trait cohort from Siwa Oasis, Egypt.埃及锡瓦绿洲镰状细胞性状队列中 -158 Gγ (C→T) 1 多态性的基因型频率研究。
J Genet. 2018 Jun;97(2):505-511.
6
Fetal haemoglobin induction in sickle cell disease.镰状细胞病中胎儿血红蛋白的诱导
Br J Haematol. 2018 Jan;180(2):189-200. doi: 10.1111/bjh.15021. Epub 2017 Nov 16.
7
Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemias.羟基脲用于减少非输血依赖型β地中海贫血的输血需求
Cochrane Database Syst Rev. 2016 Oct 18;10(10):CD011579. doi: 10.1002/14651858.CD011579.pub2.
8
A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population.伊朗人群中β地中海贫血基因型与表型相关性的大型队列研究。
Int J Hematol Oncol Stem Cell Res. 2015 Oct 1;9(4):198-202.
9
A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.对羟基脲诱导胎儿血红蛋白治疗镰状细胞病已知机制的系统评价。
Expert Rev Hematol. 2015 Oct;8(5):669-79. doi: 10.1586/17474086.2015.1078235. Epub 2015 Sep 1.
10
Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.Xmn1 -158 γG变异体与重型β地中海贫血和镰状细胞贫血的严重程度及胎儿血红蛋白水平的关联
Mol Biol Rep. 2014 May;41(5):3331-7. doi: 10.1007/s11033-014-3195-5. Epub 2014 Feb 2.

本文引用的文献

1
Xmn1-G γ polymorphism and clinical predictors of severity of disease in β-thalassemia intermedia.Xmn1-Gγ 多态性与β-地中海贫血中间型疾病严重程度的临床预测因子。
Pediatr Blood Cancer. 2011 Dec 1;57(6):1025-8. doi: 10.1002/pbc.23175. Epub 2011 Jul 13.
2
Fetal hemoglobin in sickle cell anemia.镰状细胞贫血中的胎儿血红蛋白。
Blood. 2011 Jul 7;118(1):19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13.
3
Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.坦桑尼亚和英国镰状细胞贫血症患者胎儿血红蛋白的遗传学。
Blood. 2011 Jan 27;117(4):1390-2. doi: 10.1182/blood-2010-08-302703. Epub 2010 Nov 10.
4
Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.胎儿血红蛋白的调控:基因组学带来的新见解及临床意义
Hum Mol Genet. 2009 Oct 15;18(R2):R216-23. doi: 10.1093/hmg/ddp401.
5
The Xmn1 polymorphic site 5' to the (G)gamma gene and its correlation to the (G)gamma:(A)gamma ratio, age at first blood transfusion and clinical features in beta-thalassemia patients from Western Iran.伊朗西部β地中海贫血患者中,(G)γ基因5'端的Xmn1多态性位点及其与(G)γ:(A)γ比值、首次输血年龄和临床特征的相关性。
Mol Biol Rep. 2010 Jan;37(1):159-64. doi: 10.1007/s11033-009-9566-7. Epub 2009 May 15.
6
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.解析镰状细胞病:重新评估溶血在临床亚表型发展中的作用。
Blood Rev. 2007 Jan;21(1):37-47. doi: 10.1016/j.blre.2006.07.001. Epub 2006 Nov 7.
7
XmnI polymorphism is associated with fetal hemoglobin levels in hypoplastic syndromes.XmnI基因多态性与再生障碍性贫血综合征中的胎儿血红蛋白水平相关。
Sao Paulo Med J. 2006 Mar 2;124(2):110-1. doi: 10.1590/s1516-31802006000200012.
8
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.镰状细胞性腿部溃疡:与溶血以及Klotho、TEK和TGF-β/BMP信号通路相关基因中的单核苷酸多态性的关联
Br J Haematol. 2006 Jun;133(5):570-8. doi: 10.1111/j.1365-2141.2006.06074.x.
9
Hemoglobin E-beta thalassemia: factors affecting phenotype.血红蛋白E-β地中海贫血:影响表型的因素
Indian Pediatr. 2005 Apr;42(4):357-62.
10
Burden of genetic disorders in India.印度遗传性疾病的负担。
Indian J Pediatr. 2000 Dec;67(12):893-8. doi: 10.1007/BF02723953.